Results 201 to 210 of about 3,449 (222)

[Platelet transfusion refractoriness and effective management of platelet alloimmunization].

Nihon rinsho. Japanese journal of clinical medicine, 1997
Platelet transfusion recipients become alloimmunized to foreign HLA and HPA antigens, impairing their responses to further platelet transfusions (platelet transfusion refractoriness; PTR). Anti-HLA and HPA antibodies account for the majority of clinically significant alloimmunizations.
openaire   +1 more source

Platelet Transfusion Refractory Patients

2019
Christopher A. Tormey, Jeanne E. Hendrickson   +1 more
openaire   +1 more source

PLATELET TRANSFUSION REFRACTORINESS (PTR) IN A TERTIARY REFERRAL HOSPITAL

Transfusion and Apheresis Science, 2021
I. García-Bosque, D. Hernández-Maraver, A. Kerguelen, V. Jiménez-Yuste, A. Viejo   +4 more
openaire   +2 more sources

Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial

Lancet, The, 2016
Charlotte Cordonnier, Rustam Al-Shahi Salman, Ludo F Beenen   +2 more
exaly  

[Refractoriness to platelet transfusions].

Medicina clinica, 2003
Eduardo, Muñiz-Díaz, Clara, Martínez, Pedro, Madoz   +2 more
openaire   +1 more source

Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study

Lancet, The, 2012
Roland Conradi
exaly  

Successful use of rituximab in platelet transfusion refractoriness in a multi-transfused patient with myelodysplastic syndrome

Platelets, 2015
Baodong Ye
exaly  

[Refractoriness to platelet transfusion].

Ryoikibetsu shokogun shirizu, 1999
H, Tsurumi, T, Hara, H, Moriwaki
openaire   +1 more source

Platelet Transfusion Refractory Patients

2013
openaire   +1 more source

Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial

Lancet, The, 2017
Sophia Archuleta, Dale Fisher, Limin Wijaya   +2 more
exaly